Close

INVESTOR ALERT: Khang & Khang LLP Announces An Investigation Of Claims Against Dr. Reddy’s Laboratories Ltd. And Advises Investors To Contact The Firm

November 11, 2015 1:02 PM EST

IRVINE, Calif.--(BUSINESS WIRE)-- Khang & Khang LLP announces that it is investigating claims of potential misrepresentations by Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s” or the “Company”) (NYSE: RDY). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased shares of Dr. Reddy’s during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by email at [email protected].

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

On November 6, 2015, the Company announced that it received a warning letter from the U.S. Food and Drug Administration over inadequate quality control procedures at three manufacturing plants in India. When the truth was revealed, shares dropped causing investors harm.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by email at [email protected].

This press release may constitute Attorney Advertising in some jurisdictions.

KHANG & KHANG LLP
Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
[email protected]

Source: Khang & Khang LLP



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Press Releases